Pulmonary artery catheterization in acute coronary syndromes: Insights from the GUSTO IIb and GUSTO III trials Mauricio G. Cohen, MD, Robert V. Kelly, MD, David F. Kong, MD, Venu Menon, MD, Monica Shah, MD, Jorge Ferreira, MD, Karen S. Pieper, MS, Douglas Criger, MPH, Rosana Poggio, MD, E. Magnus Ohman, MD, Joel Gore, MD, Robert M. Califf, MD, Christopher B. Granger, MD The American Journal of Medicine Volume 118, Issue 5, Pages 482-488 (May 2005) DOI: 10.1016/j.amjmed.2004.12.018 Copyright © 2005 Elsevier Inc. Terms and Conditions
Figure 1 Resource utilization. PAC = pulmonary artery catheterization; PCI = percutaneous coronary intervention; CABG = coronary artery bypass grafting; IABP = intraaortic balloon pump. The American Journal of Medicine 2005 118, 482-488DOI: (10.1016/j.amjmed.2004.12.018) Copyright © 2005 Elsevier Inc. Terms and Conditions
Figure 2 Unadjusted major adverse cardiac events. PAC = pulmonary artery catheterization; CHF = congestive heart failure. The American Journal of Medicine 2005 118, 482-488DOI: (10.1016/j.amjmed.2004.12.018) Copyright © 2005 Elsevier Inc. Terms and Conditions